RED Full risk-off day.
Cash is a position
Regime: RED
The Picks
| Ticker | Scan Price | Gap % | RVOL | Catalyst | ML Hold Prob | ML Expected |
|---|---|---|---|---|---|---|
| IBIT | $40.73 | 11.28 | 44.13 | Btc Sympathy: Bitcoin surged above $71,000 driven by positive sentiment and massive short liquidations, benefiting IBIT as a Bitcoin spot ETF with direct exposure to BTC price movements. | — | — |
| BITB | $38.99 | 11.18 | 48.12 | Sector: Spot Bitcoin ETF flows and broader crypto strength appear to be lifting BITB, with no single BITB-specific catalyst identified in the latest headlines [via web] | — | — |
| MRK | $150.00 | 10.97 | 41.62 | Analyst: A Merck analyst upgraded the stock, placing it among the top 5 upgrades for Thursday. | — | — |
| ARKG | $47.02 | 8.81 | 35.40 | Partnership: Merck and Moderna's cancer vaccine breakthrough partnership could drive investor interest in mRNA technology holdings within ARKG's genomics and biotech portfolio. | — | — |
| WPM | $144.95 | 9.23 | 37.32 | Sector: Government deficit spending is driving demand for mining commodities, positioning WPM to benefit from the broader mining supercycle. | — | — |
The Results
| Ticker | Entry | Entry Time | Exit | Exit Time | Method | P/L | % | Catalyst |
|---|---|---|---|---|---|---|---|---|
| IBIT | $40.73 | $41.09 | 3:20 PM | Shadow | $89.43 | 0.90 | Btc Sympathy: Bitcoin surged above $71,000 driven by positive sentiment and massive short liquidations, benefiting IBIT as a Bitcoin spot ETF with direct exposure to BTC price movements. | |
| BITB | $38.99 | $39.37 | 3:20 PM | Shadow | $96.00 | 0.96 | Sector: Spot Bitcoin ETF flows and broader crypto strength appear to be lifting BITB, with no single BITB-specific catalyst identified in the latest headlines [via web] | |
| MRK | $150.00 | $150.86 | 3:20 PM | Shadow | $56.76 | 0.57 | Analyst: A Merck analyst upgraded the stock, placing it among the top 5 upgrades for Thursday. | |
| ARKG | $47.02 | $47.78 | 3:20 PM | Shadow | $162.18 | 1.63 | Partnership: Merck and Moderna's cancer vaccine breakthrough partnership could drive investor interest in mRNA technology holdings within ARKG's genomics and biotech portfolio. | |
| WPM | $144.95 | $149.02 | 3:20 PM | Shadow | $276.76 | 2.81 | Sector: Government deficit spending is driving demand for mining commodities, positioning WPM to benefit from the broader mining supercycle. |
Shadow Results
| Ticker | Shadow Entry | Shadow Exit | Exit Time | Method | Shadow P/L | % | Result | Catalyst |
|---|---|---|---|---|---|---|---|---|
| IBIT | $40.73 | $41.09 | 3:20 PM | Shadow | $89.43 | 0.90 | WIN | Btc Sympathy: Bitcoin surged above $71,000 driven by positive sentiment and massive short liquidations, benefiting IBIT as a Bitcoin spot ETF with direct exposure to BTC price movements. |
| BITB | $38.99 | $39.37 | 3:20 PM | Shadow | $96.00 | 0.96 | WIN | Sector: Spot Bitcoin ETF flows and broader crypto strength appear to be lifting BITB, with no single BITB-specific catalyst identified in the latest headlines [via web] |
| MRK | $150.00 | $150.86 | 3:20 PM | Shadow | $56.76 | 0.57 | WIN | Analyst: A Merck analyst upgraded the stock, placing it among the top 5 upgrades for Thursday. |
| ARKG | $47.02 | $47.78 | 3:20 PM | Shadow | $162.18 | 1.63 | WIN | Partnership: Merck and Moderna's cancer vaccine breakthrough partnership could drive investor interest in mRNA technology holdings within ARKG's genomics and biotech portfolio. |
| WPM | $144.95 | $149.02 | 3:20 PM | Shadow | $276.76 | 2.81 | WIN | Sector: Government deficit spending is driving demand for mining commodities, positioning WPM to benefit from the broader mining supercycle. |
Things to Explore
Interested in our research, validation methodology, and trading system?
Get in TouchWork With Diana
Need a context architect to scaffold your AI agents and facilitate structured learning?
Visit goddev.aiThis post is part of a series documenting MorningEdge's development in real time. The knowledge base contains 0 books, papers, and lab reports totaling 0+ searchable chunks. The trading system described is paper trading only — no real capital is at risk.